BUSINESS● LOW13h ago · Oct 14, 2026, 9:14 PM
Lakefront sells early-stage CAR-T programs to Armed Cell Therapeutics
Seeking Alpha Tech · global
Lakefront has sold its early-stage CAR-T programs to Armed Cell Therapeutics, indicating a transaction involving biotech assets. This news is relevant to the pharmaceutical and investment communities.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowEthiopia, Guinea, Benin… Which African countries show the strongest economic growth?Jeune AfriqueBUSINESS21m agoWill investors sell the Rangers and buy the Knicks after the MSGS spinoff?Seeking Alpha Tech